Clinical Trial Update: 68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 68Ga-FAPI-04 and 18F-FDG PET/CT in epithelial ovarian cancer with comparison to histology findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)
• 68Ga-FAPI-04

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Epithelial Ovarian Cancer | Phase 2 | Status: UNKNOWN